C. Romei, E. Pardi, F. Cetani, R. Elisei, Genetic and clinical features of multiple endocrine neoplasia types 1 and 2. J. Oncol. 2012, 705036 (2012)

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cancer Genome Atlas Research Network, Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676–690 (2014)

Article  Google Scholar 

R. Ciampi, C. Romei, T. Ramone, A. Prete, A. Tacito, V. Cappagli, V. Bottici, D. Viola, L. Torregrossa, C. Ugolini, F. Basolo, R. Elisei, Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted Sequencing. IScience 20, 324–336 (2019)

Article  CAS  PubMed  PubMed Central  Google Scholar 

I. Landa, T. Ibrahimpasic, L. Boucai, R. Sinha, J.A. Knauf, R.H. Shah, S. Dogan, J.C. Ricarte-Filho, G.P. Krishnamoorthy, B. Xu, N. Schultz, M.F. Berger, C. Sander, B.S. Taylor, R. Ghossein, I. Ganly, J.A. Fagin, Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Investig. 126, 1052–1066 (2016)

Article  PubMed  PubMed Central  Google Scholar 

C. Romei, R. Elisei, A Narrative Review of Genetic Alterations in Primary Thyroid Epithelial Cancer. Int J. Mol. Sci. 22, 1726 (2021)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L. Valerio, L. Pieruzzi, C. Giani, L. Agate, V. Bottici, L. Lorusso, V. Cappagli, L. Puleo, A. Matrone, D. Viola, C. Romei, R. Ciampi, E. Molinaro, R. Elisei, Targeted Therapy in Thyroid Cancer: State of the Art. Clin. Oncol. 29, 316–324 (2017)

Article  CAS  Google Scholar 

E. Arighi, M.G. Borrello, H. Sariola, RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev. 16, 441–467 (2005)

Article  CAS  PubMed  Google Scholar 

K. Kawai, M. Takahashi, Intracellular RET signaling pathways activated by GDNF. Cell Tissue Res. 382, 113–123 (2020)

Article  CAS  PubMed  Google Scholar 

A. Cerrato, V. De Falco, M. Santoro, Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets. J. Mol. Endocrinol. 43, 143–155 (2009)

Article  CAS  PubMed  Google Scholar 

M. Santoro, R.M. Melillo, F. Carlomagno, A. Fusco, G. Vecchio, Molecular mechanisms of RET activation in human cancer. Ann. N. Y Acad. Sci. 963, 116–121 (2002)

Article  CAS  PubMed  Google Scholar 

R. Elisei, A. Tacito, T. Ramone, R. Ciampi, V. Bottici, V. Cappagli, D. Viola, A. Matrone, L. Lorusso, L. Valerio, C. Giani, C. Campopiano, A. Prete, L. Agate, E. Molinaro, C. Romei, Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations. Genes (Basel) 10, 698 (2019)

Article  CAS  PubMed  Google Scholar 

F. Raue, K. Frank-Raue, Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma. J. Endocr. Soc. 2, 933–943 (2018)

Article  CAS  PubMed  PubMed Central  Google Scholar 

L.M. Mulligan, RET revisited: expanding the oncogenic portfolio. Nat. Rev. Cancer 14, 173–186 (2014)

Article  CAS  PubMed  Google Scholar 

S.A. Wells, Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors. Endocr. Relat. Cancer 25, T1 (2018)

Article  PubMed  Google Scholar 

C. Romei, R. Ciampi, R. Elisei, A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat. Rev. Endocrinol. 12, 192–202 (2016)

Article  CAS  PubMed  Google Scholar 

L.M. Mulligan, J.B.J. Kwok, C.S. Healey, M.J. Elsdon, C. Eng, E. Gardner, D.R. Love, S.E. Mole, J.K. Moore, L. Papi, M.A. Ponder, H. Telenius, A. Tunnacliffe, B.A.J. Ponder, Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458–460 (1993)

Article  CAS  PubMed  Google Scholar 

O. Gimm, D.J. Marsh, S.D. Andrew, A. Frilling, P.L. Dahia, L.M. Mulligan, J.D. Zajac, B.G. Robinson, C. Eng, Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J. Clin. Endocrinol. Metab. 82, 3902–3904 (1997)

Article  CAS  PubMed  Google Scholar 

F. Castinetti, S.G. Waguespack, A. Machens, S. Uchino, K. Hasse-Lazar, G. Sanso, T. Else, S. Dvorakova, X.P. Qi, R. Elisei, A.L. Maia, J. Glod, D.M. Lourenço, N. Valdes, J. Mathiesen, N. Wohllk, T.R. Bandgar, D. Drui, M. Korbonits, M.R. Druce, C. Brain, T. Kurzawinski, A. Patocs, M.J. Bugalho, A. Lacroix, P. Caron, P. Fainstein-Day, F. Borson Chazot, M. Klein, T.P. Links, C. Letizia, L. Fugazzola, O. Chabre, L. Canu, R. Cohen, A. Tabarin, A. Spehar Uroic, D. Maiter, S. Laboureau, C. Mian, M. Peczkowska, F. Sebag, T. Brue, D. Mirebeau-Prunier, L. Leclerc, B. Bausch, A. Berdelou, A. Sukurai, P. Vlcek, J. Krajewska, M. Barontini, C. Vaz Ferreira Vargas, L. Valerio, L. Ceolin, S. Akshintala, A. Hoff, C. Godballe, B. Jarzab, C. Jimenez, C. Eng, T. Imai, M. Schlumberger, E. Grubbs, H. Dralle, H.P. Neumann, E. Baudin, Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study. Lancet Diabetes Endocrinol. 7, 213–220 (2019)

Article  PubMed  PubMed Central  Google Scholar 

D.K. Crockett, S.R. Piccolo, P.G. Ridge, R.L. Margraf, E. Lyon, M.S. Williams, J.A. Mitchell, Predicting phenotypic severity of uncertain gene variants in the RET proto-oncogene. PLoS ONE 6, e18380 (2011)

Article  CAS  PubMed  PubMed Central  Google Scholar 

B. Cosci, A. Vivaldi, C. Romei, F. Gemignani, S. Landi, R. Ciampi, A. Tacito, E. Molinaro, L. Agate, V. Bottici, V. Cappagli, D. Viola, P. Piaggi, P. Vitti, A. Pinchera, R. Elisei, In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. Endocr. Relat. Cancer 18, 603–612 (2011)

Article  CAS  PubMed  Google Scholar 

R.L. Margraf, D.K. Crockett, P.M.F. Krautscheid, R. Seamons, F.R.O. Calderon, C.T. Wittwer, R. Mao, Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations. Hum. Mutat. 30, 548–556 (2009)

Article  CAS  PubMed  Google Scholar 

C. Romei, B. Cosci, G. Renzini, V. Bottici, E. Molinaro, L. Agate, P. Passannanti, D. Viola, A. Biagini, F. Basolo, C. Ugolini, G. Materazzi, A. Pinchera, P. Vitti, R. Elisei, RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clin. Endocrinol. (Oxf.) 74, 241–247 (2011)

Article  CAS  PubMed  Google Scholar 

R. Elisei, R. Ciampi, A. Matrone, A. Prete, C. Gambale, T. Ramone, G. Simeakis, G. Materazzi, L. Torregrossa, C. Ugolini, C. Romei, Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib. J. Clin. Endocrinol. Metab. 107, 2195–2202 (2022)

Article  PubMed  Google Scholar 

C. Romei, F. Casella, A. Tacito, V. Bottici, L. Valerio, D. Viola, V. Cappagli, A. Matrone, R. Ciampi, P. Piaggi, C. Ugolini, L. Torregrossa, F. Basolo, G. Materazzi, P. Vitti, R. Elisei, New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations. J. Med. Genet. 53, 729–734 (2016)

Article  CAS  PubMed  Google Scholar 

C. Mian, G. Pennelli, S. Barollo, E. Cavedon, D. Nacamulli, F. Vianello, I. Negro, G. Pozza, I.M. Boschin, M.R. Pelizzo, M. Rugge, F. Mantero, M.E. Girelli, G. Opocher, Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur. J. Endocrinol. 164, 971–976 (2011)

Article  CAS  PubMed  Google Scholar 

M.M. Moura, B.M. Cavaco, A.E. Pinto, R. Domingues, J.R. Santos, M.O. Cid, M.J. Bugalho, V. Leite, Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas. Br. J. Cancer 100, 1777–1783 (2009)

Article  CAS  PubMed  PubMed Central  Google Scholar 

R. Elisei, B. Cosci, C. Romei, V. Bottici, G. Renzini, E. Molinaro, L. Agate, A. Vivaldi, P. Faviana, F. Basolo, P. Miccoli, P. Berti, F. Pacini, A. Pinchera, Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J. Clin. Endocrinol. Metab. 93, 682–687 (2008)

Article  CAS  PubMed  Google Scholar 

T. Ramone, C. Mulè, R. Ciampi, V. Bottici, V. Cappagli, A. Prete, A. Matrone, P. Piaggi, L. Torregrossa, F. Basolo, R. Elisei, C. Romei, RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency. Genes (Basel) 12, 35 (2020)

Article  PubMed  Google Scholar 

C. Mulè, R. Ciampi, T. Ramone, A. Prete, A. Matrone, V. Cappagli, L. Torregrossa, F. Basolo, R. Elisei, C. Romei, Higher RET Gene Expression Levels Do Not Represent anAlternative RET Activation Mechanism in Medullary Thyroid Carcinoma. Biomolecules 11, 1542 (2021)

Article  PubMed  PubMed Central  Google Scholar 

M. Santoro, M. Moccia, G. Federico, F. Carlomagno, RET Gene Fusions in Malignancies of the Thyroid and Other Tissues. Genes (Basel) 11, 424 (2020)

Article  CAS  PubMed  Google Scholar 

R. Elisei, C. Romei, T. Vorontsova, B. Cosci, V. Veremeychik, E. Kuchinskaya, F. Basolo, E.P. Demidchik, P. Miccoli, A. Pinchera, F. Pacini, RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J. Clin. Endocrinol. Metab. 86, 3211–3216 (2001)

CAS  PubMed  Google Scholar 

Y.E. Nikiforov, J.M. Rowland, K.E. Bove, H. Monforte-Munoz, J.A. Fagin, Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res. 57, 1690–1694 (1997)

CAS  PubMed  Google Scholar 

A.G. Saad, S. Kumar, E. Ron, J.H. Lubin, J. Stanek, K.E. Bove, Y.E. Nikiforov, Proliferative activity of human thyroid cells in various age groups and its correlation with the risk of thyroid cancer after radiation exposure. J. Clin. Endocrinol. Metab. 91, 2672–2677 (2006)